IE
RXST icon

Israel Englander’s RxSight RXST Stock Holding History

Israel Englander’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-30,000
Closed -$837K – 6471
2023
Q3 		$837K Buy
+30,000
New +$894K ﹤0.01% 4308

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Israel Englander's RXST Position: Q2 2026 in Review

Israel Englander increased its RxSight (RXST) stake by 47% in Q2 2026, buying an estimated $5.86M and bringing the position to 3,030,287 shares worth $14.6M. The position accounts for 0.01% of the portfolio, ranked #1921.

Israel Englander first reported a position in RXST in Q3 2021 and has held it in 20 quarters since. The position peaked at $35.5M in Q2 2023. 150 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Israel Englander held 3,030,287 shares of RxSight worth $14.6M as of Q2 2026.
  • Israel Englander bought 970,828 RxSight shares in Q2 2026, an estimated $5.86M.
  • RxSight made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1921 holding.
  • Israel Englander first reported a position in RxSight in Q3 2021 and has held it in 20 quarters since.
  • Israel Englander's RxSight position peaked at $35.5M in Q2 2023.
  • 150 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.